OpenVSafe by OpenVAERS
Search V-safe

ZDD-29648-63351

1 vaccination 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
600 / IL
Registered
2021-03-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-23
    Registered in v-safe
  2. 2021-03-23
    Dose 1 — Moderna
  3. 2021-03-23
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  4. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-09-21
    Survey response — 6 months, dose 1
    MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Fair
    Free text: Cold/cold symptoms (congestion, runny nose, sneezing, sore throat)
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-23Moderna

Free text

Release 9 — 6 months, dose 1

2021-09-21

Symptoms: Cold/cold symptoms (congestion, runny nose, sneezing, sore throat)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release